Femoston (estradiol dydrogesterone): Reviews and patient testimonials

Femoston 1/10mg

Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women at least 6 months since last menses.

Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis. (See also section 4.4)

The experience in treating women older than 65 years is limited.

Femoston 2/10mg

Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women at least 6 months since last menses.

Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis. (See also section 4.4)

The experience in treating women older than 65 years is limited.

Femoston-conti 0.5mg/2.5mg

Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women at least 12 months since last menses.

The experience in treating women older than 65 years is limited.

Femoston-conti 1mg/ 5mg film-coated tablets

Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women at least 12 months since last menses.

Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis. (See also section 4.4)

The experience in treating women older than 65 years is limited.

Route of administration: Oral
Molecule: estradiol, dydrogesterone